F. Hoffmann-La Roche, the manufacturer of the antiviral Tamiflu, has launched a program under which US companies that have a designated person on staff skilled with flu diagnosis can stockpile
supplies of the drug in preparation for distribution to employees in
the event of a pandemic.
To read more, click here...
To read the F. Hoffmann-La Roche press release, click here...
To read the F. Hoffmann-La Roche press release, click here...
